praziquantel has been researched along with Recrudescence in 106 studies
azinox: Russian drug
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-eight Zairean patients with Schistosoma mansoni infection were investigated and treated with praziquantel." | 9.06 | Re-infection in human schistosomiasis mansoni: a prospective field study 18 months after praziquantel therapy. ( Feldmeier, H; Harms, G; Müller, O; Poggensee, U; Steiner, A; Zwingenberger, K, 1990) |
| "Nineteen cases of acute schistosomiasis patients whose temperatures had fallen to normal automatically were treated with praziquantel, and their temperatures recrudesced after the treatment." | 7.77 | [Temperature recrudescence caused by praziquantel treatment after falling to normal automatically in acute schistosomiasis patients: a report of 19 cases]. ( Zhang, SX; Zhang, TY, 2011) |
| "A case of fourth ventricle cysticercosis treated with praziquantel is presented." | 7.68 | Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy. ( Botana, C; Fandiño, C; Fandiño, J; Gomez-Bueno, J; Rodriguez, D, 1991) |
| "Standard therapeutic regimens of praziquantel for neurocysticercosis use daily doses of 50 mg/kg for 15-21 days, with prolonged remission being achieved in 60-80% patients." | 7.68 | High-dose praziquantel for neurocysticercosis: efficacy and tolerability. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Mazer, S; Oliveira, TV, 1990) |
| "Ultrasonographic examination of the liver and biliary system using a portable ultrasound unit was performed in 1987 in 647 opisthorchiasis patients who had been treated with praziquantel during 1981 to 1986." | 7.67 | Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel. ( Pungpak, S; Sornmani, S; Suntharasamai, P; Vivatanasesth, P, 1989) |
| "Twenty-eight Zairean patients with Schistosoma mansoni infection were investigated and treated with praziquantel." | 5.06 | Re-infection in human schistosomiasis mansoni: a prospective field study 18 months after praziquantel therapy. ( Feldmeier, H; Harms, G; Müller, O; Poggensee, U; Steiner, A; Zwingenberger, K, 1990) |
| " The participants with advanced periductal fibrosis (APF) by ultrasound (n = 785) were invited to undergo annual follow-up ultrasonography for five years after praziquantel treatment." | 4.02 | Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study. ( Bethony, J; Brindley, PJ; Kaewkes, S; Laha, T; Loukas, A; Mairiang, E; Sripa, B, 2021) |
| "Nineteen cases of acute schistosomiasis patients whose temperatures had fallen to normal automatically were treated with praziquantel, and their temperatures recrudesced after the treatment." | 3.77 | [Temperature recrudescence caused by praziquantel treatment after falling to normal automatically in acute schistosomiasis patients: a report of 19 cases]. ( Zhang, SX; Zhang, TY, 2011) |
| "The aim of the present study was to evaluate the efficacy of praziquantel treatment of Schistosoma japonicum infections in cattle and water buffaloes and to assess the natural rate of reinfection after treatment." | 3.73 | Treatment and reinfection of water buffaloes and cattle infected with Schistosoma japonicum in Yangtze River Valley, Anhui province, China. ( Johansen, MV; Lu, D; Ornbjerg, N; Wang, T; Wu, W; Zhang, G; Zhang, S, 2006) |
| "A prospective cohort study was conducted in two villages in Zambia to compare the efficacy of praziquantel in the treatment of schistosomiasis haematobium in people with and without concomitant infection with human immunodeficiency virus (HIV)." | 3.72 | Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. ( Ernest, A; Mwanakasale, V; Sukwa, TY; Tanner, M; Vounatsou, P; Ziba, M, 2003) |
| "A case of fourth ventricle cysticercosis treated with praziquantel is presented." | 3.68 | Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy. ( Botana, C; Fandiño, C; Fandiño, J; Gomez-Bueno, J; Rodriguez, D, 1991) |
| "Standard therapeutic regimens of praziquantel for neurocysticercosis use daily doses of 50 mg/kg for 15-21 days, with prolonged remission being achieved in 60-80% patients." | 3.68 | High-dose praziquantel for neurocysticercosis: efficacy and tolerability. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Mazer, S; Oliveira, TV, 1990) |
| "Ultrasonographic examination of the liver and biliary system using a portable ultrasound unit was performed in 1987 in 647 opisthorchiasis patients who had been treated with praziquantel during 1981 to 1986." | 3.67 | Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel. ( Pungpak, S; Sornmani, S; Suntharasamai, P; Vivatanasesth, P, 1989) |
| "Schistosoma mansoni infection is proven to be a major health problem of preschool-age children in sub-Saharan Africa, yet this age category is not part of the schistosomiasis control program." | 2.80 | Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial. ( Nalugwa, A; Nuwaha, F; Olsen, A; Tukahebwa, EM, 2015) |
| "Sparganosis is an infectious disease caused by a larval tapeworm of the genus Spirometra, which commonly invades subcutaneous tissues." | 2.66 | Recurrent eosinophilic pleuritis caused by sparganum infection: A case report and review of the literature. ( Fang, L; Gao, Q; Wang, Y; Yan, B; Zhou, J, 2020) |
| " Two dosage regimes were compared, a single dose of 40 mg/kg bodyweight, and a divided dose 2 X 20 mg/kg given 4-6 h apart." | 2.66 | Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan. ( Daffalla, AA; Dixon, HG; el Igail, AB; el Tayeb, M; Fenwick, A; Kardaman, MW, 1985) |
| "Schistosomiasis is a major disease of public health importance in humans occurring in over 70 countries of the tropics and sub-tropics." | 2.43 | Implementation of human schistosomiasis control: Challenges and prospects. ( Fenwick, A; Rollinson, D; Southgate, V, 2006) |
| "MR-tomography showed an internal hydrocephalus and multiple contrast enhancing parenchymal cysts." | 2.40 | [Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases]. ( Delcker, A; Häussermann, P; Koeppen, S; Wiegand, F, 1999) |
| "Seizures were easily controlled." | 2.37 | Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. ( Crawford, TO; Mitchell, WG, 1988) |
| "Prominent recrudescence of infection from 2." | 1.62 | Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: Repeated cross-sectional studies. ( Abubakar, S; Ali, SM; Ame, SM; Hattendorf, J; Juma, S; Kabole, F; Knopp, S; Rollinson, D; Trippler, L, 2021) |
| "The treatment of choice in renal hydatid cyst is surgery; although there are some reports about the efficacy of medical treatments for hydatid cysts but lower rates of recurrence and higher efficacy put surgery in a superior position compared to medical approaches." | 1.56 | Medical treatment for an isolated renal multilocular hydatid cyst in an elderly: a case report. ( Asefi, H; Moghtadaie, A; Mohraz, M; Razeghi, E; Yazdi, SAM, 2020) |
| "Opisthorchis viverrini infection is highly prevalent in northeast Thailand." | 1.51 | Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand. ( Gray, DJ; Kelly, MJ; Khuntikeo, N; Sithithaworn, P; Suwannatrai, AT; Thinkhamrop, K; Thinkhamrop, W; Wangdi, K, 2019) |
| "Human cystic echinococcosis (CE) and alveolar echinococcosis (AE) are highly endemic in Tibetan communities of Sichuan Province." | 1.43 | Seasonal pattern of Echinococcus re-infection in owned dogs in Tibetan communities of Sichuan, China and its implications for control. ( Craig, PS; Giraudoux, P; He, W; Huang, L; Huang, Y; Mastin, A; Shang, JY; Wang, Q; Wu, WP; Yu, WJ; Zhang, GJ; Zhong, B, 2016) |
| "Since these trematodes are zoonoses, preventive chemotherapy may not have sufficient impact alone on the transmission to have a lasting effect on the prevalence." | 1.40 | High reinfection rate after preventive chemotherapy for fishborne zoonotic trematodes in Vietnam. ( Asfeldt, AM; Dalsgaard, A; Do, DT; Johansen, MV; Lier, T; Nguyen, TH, 2014) |
| " In this work, we analyze the adverse effects seen in 57 patients diagnosed with hydatidosis who were treated with praziquantel plus albendazole combined therapy between 2006 and 2010." | 1.40 | Safety of the combined use of praziquantel and albendazole in the treatment of human hydatid disease. ( Alvela-Suárez, L; Belhassen-Garcia, M; Cordero-Sánchez, M; Novo-Veleiro, I; Pardo-Lledías, J; Pérez del Villar, L; Romero-Alegría, A; Valverde-Merino, MP; Velasco-Tirado, V, 2014) |
| " multilocularis transmission within local pastoral communities, and thus dog dosing could be an effective strategy to reduce transmission of E." | 1.39 | Reinfection studies of canine echinococcosis and role of dogs in transmission of Echinococcus multilocularis in Tibetan communities, Sichuan, China. ( Chen, X; Craig, PS; Giraudoux, P; Ito, A; Li, T; Moss, JE; Qiu, J; Torgerson, PR; Wang, Q, 2013) |
| "High intensities in mixed infections may influence disease epidemiology and control warranting further studies." | 1.39 | Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns. ( Diaw, OT; Faye, DS; Rollinson, D; Seye, MM; Sousa-Figueiredo, JC; Stothard, JR; Webster, BL, 2013) |
| " Adverse events were monitored within 4h after dosing by the survey team and 24h after treatment using a questionnaire." | 1.39 | Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger. ( Barkiré, N; Djibo, A; Fenwick, A; Garba, A; Gouvras, AN; Labbo, R; Lamine, MS; Sebangou, H; Sofo, B; Utzinger, J; Webster, JP, 2013) |
| "There are only few urinary schistosomiasis cases reported from Turkey." | 1.38 | [A case of persistent urinary schistosomiasis transmitted through Lake Malawi]. ( Gedik, H; Kantürk, A; Simşek, F; Yıldırmak, MT, 2012) |
| "Praziquantel treatment for Schistosoma mansoni infection enhances Th2 responsiveness against parasite Ags, but also increases the variance in Ab isotype levels." | 1.33 | Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levels. ( Booth, M; Carpenter, D; Dunne, DW; Jones, FM; Joseph, S; Kabatereine, NB; Kariuki, HC; Mwatha, JK; Ouma, JH; Shaw, MA; Vennervald, BJ, 2006) |
| "Recurrence of fever is not unusual despite anti-helminthic treatment." | 1.33 | Imported Katayama fever: clinical and biological features at presentation and during treatment. ( Bottieau, E; Clerinx, J; Colebunders, R; de Vega, MR; Van den Ende, J; Van den Enden, E; Van Esbroeck, M; Van Gompel, A; Vervoort, T, 2006) |
| " The recommended dosage of PZQ is a single 40 mg/kg oral dose, and each of these patients continued to pass viable Schistosoma mansoni eggs despite three successive doses at or above this level." | 1.33 | Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. ( Amer, N; Bennett, JL; Botros, S; Day, TA; El-Ghannam, M; Sayed, H, 2005) |
| "Praziquantel treatment was highly efficacious at three weeks after treatment when judged by egg reduction rate (95." | 1.32 | Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. ( Appleton, CC; Becker, W; Kvalsvig, JD; Magnussen, P; Olsen, A; Saathoff, E, 2004) |
| "Praziquantel was given every eight weeks for two years to children aged under six years of age, living in a Schistosoma haematobium endemic area." | 1.31 | The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection. ( Chandiwana, SK; Hagan, P; Madziwa, TM; Mduluza, T; Midzi, N; Ndhlovu, PD; Nyazema, N; Turner, CM; Zinyama, R, 2001) |
| "Surgery for disease recurrence carries a high risk of mortality." | 1.30 | Medical decompression of vertebral hydatidosis. ( Faraj, A; Finch, RG; Lam, KS; Mulholland, RC, 1997) |
| "A 33-year-old patient with AIDS, and a history of episodes of Pneumocystis carinii pneumonia and cerebral toxoplasmosis, developed a subcutaneous paravertebral infiltrate, which at first resembled a haematoma." | 1.28 | [Taenia crassiceps infection in AIDS]. ( Gross, U; Joeres, R; Klinker, H; Landwehr, P; Müller, J; Richter, E; Schmidt-Rotte, H; Tintelnot, K, 1992) |
| "Epilepsy is the most common presentation, but it has many other variable forms of neurological manifestations." | 1.28 | Neurocysticercosis: an under-recognized cause of neurological problems. ( Collignon, PJ; Crimmins, D; Danta, G; Dwyer, D, 1990) |
| " Mild side effects increased in frequency as dosage increased, abdominal disturbance, vomiting and fever." | 1.27 | Assessment of efficacy of praziquantel against Schistosoma mansoni infection. ( Anwar, WA; el Kholy, AM; Massoud, AA, 1984) |
| "Oxamniquine was equally effective in children receiving it in both 1981 and 1983, and the efficacy of praziquantel resembled that of oxamniquine." | 1.27 | Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment. ( arap Siongok, TK; Bensted-Smith, R; Butterworth, AE; Dalton, PR; Kariuki, HC; Koech, D; Mugambi, M; Ouma, JH; Sturrock, RF, 1987) |
| "Although schistosomiasis is an important occupational hazard for irrigation workers in Central Sudan, few measures have been found to protect them, short of abandoning the work." | 1.27 | Protection of Sudanese irrigation workers from schistosome infections by a shift to earlier working hours. ( Abdu, KM; el Gaddal, AA; Jobin, WR; Tameim, O, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (15.09) | 18.7374 |
| 1990's | 35 (33.02) | 18.2507 |
| 2000's | 31 (29.25) | 29.6817 |
| 2010's | 20 (18.87) | 24.3611 |
| 2020's | 4 (3.77) | 2.80 |
| Authors | Studies |
|---|---|
| Dejon-Agobé, JC | 1 |
| Edoa, JR | 1 |
| Honkpehedji, YJ | 1 |
| Zinsou, JF | 1 |
| Adégbitè, BR | 1 |
| Ngwese, MM | 1 |
| Mangaboula, A | 1 |
| Lell, B | 1 |
| Woldearegai, TG | 1 |
| Grobusch, MP | 1 |
| Mordmüller, B | 1 |
| Adegnika, AA | 1 |
| Fang, L | 1 |
| Wang, Y | 1 |
| Gao, Q | 1 |
| Yan, B | 1 |
| Zhou, J | 1 |
| Moghtadaie, A | 1 |
| Yazdi, SAM | 1 |
| Mohraz, M | 1 |
| Asefi, H | 1 |
| Razeghi, E | 1 |
| Mairiang, E | 1 |
| Laha, T | 1 |
| Kaewkes, S | 1 |
| Loukas, A | 1 |
| Bethony, J | 1 |
| Brindley, PJ | 1 |
| Sripa, B | 1 |
| Trippler, L | 1 |
| Ame, SM | 1 |
| Hattendorf, J | 1 |
| Juma, S | 1 |
| Abubakar, S | 1 |
| Ali, SM | 1 |
| Kabole, F | 1 |
| Rollinson, D | 4 |
| Knopp, S | 1 |
| Kabuyaya, M | 1 |
| Chimbari, MJ | 1 |
| Manyangadze, T | 1 |
| Mukaratirwa, S | 1 |
| Thinkhamrop, K | 1 |
| Khuntikeo, N | 1 |
| Sithithaworn, P | 1 |
| Thinkhamrop, W | 1 |
| Wangdi, K | 1 |
| Kelly, MJ | 1 |
| Suwannatrai, AT | 1 |
| Gray, DJ | 1 |
| Carlton, EJ | 1 |
| Hubbard, A | 1 |
| Wang, S | 1 |
| Spear, RC | 1 |
| Tukahebwa, EM | 2 |
| Vennervald, BJ | 3 |
| Nuwaha, F | 2 |
| Kabatereine, NB | 2 |
| Magnussen, P | 2 |
| Tchuem Tchuenté, LA | 1 |
| Momo, SC | 1 |
| Stothard, JR | 2 |
| Moss, JE | 1 |
| Chen, X | 1 |
| Li, T | 1 |
| Qiu, J | 1 |
| Wang, Q | 2 |
| Giraudoux, P | 2 |
| Ito, A | 1 |
| Torgerson, PR | 1 |
| Craig, PS | 2 |
| Nissen, S | 1 |
| Nguyen, LA | 1 |
| Thamsborg, SM | 1 |
| Dalsgaard, A | 2 |
| Johansen, MV | 3 |
| Alvela-Suárez, L | 1 |
| Velasco-Tirado, V | 1 |
| Belhassen-Garcia, M | 1 |
| Novo-Veleiro, I | 1 |
| Pardo-Lledías, J | 1 |
| Romero-Alegría, A | 1 |
| Pérez del Villar, L | 1 |
| Valverde-Merino, MP | 1 |
| Cordero-Sánchez, M | 1 |
| Lier, T | 1 |
| Do, DT | 1 |
| Nguyen, TH | 1 |
| Asfeldt, AM | 1 |
| Nalugwa, A | 1 |
| Olsen, A | 2 |
| Kalenda, YD | 1 |
| Kato, K | 1 |
| Goto, Y | 1 |
| Fujii, Y | 1 |
| Hamano, S | 1 |
| Yu, WJ | 1 |
| Zhong, B | 1 |
| Shang, JY | 1 |
| Huang, L | 1 |
| Mastin, A | 1 |
| Huang, Y | 1 |
| Zhang, GJ | 1 |
| He, W | 1 |
| Wu, WP | 1 |
| Olveda, DU | 1 |
| McManus, DP | 3 |
| Ross, AG | 3 |
| Mwinzi, PN | 2 |
| Ganley-Leal, L | 1 |
| Black, CL | 2 |
| Secor, WE | 3 |
| Karanja, DM | 3 |
| Colley, DG | 3 |
| Muok, EM | 1 |
| Carter, JM | 1 |
| Sandhu, G | 1 |
| Georgescu, A | 1 |
| Korniyenko, A | 1 |
| Florita, C | 1 |
| Iuga, A | 1 |
| Zhang, SX | 1 |
| Zhang, TY | 1 |
| Garba, A | 3 |
| Lamine, MS | 1 |
| Barkiré, N | 1 |
| Djibo, A | 1 |
| Sofo, B | 1 |
| Gouvras, AN | 1 |
| Labbo, R | 2 |
| Sebangou, H | 1 |
| Webster, JP | 1 |
| Fenwick, A | 4 |
| Utzinger, J | 2 |
| Webster, BL | 1 |
| Diaw, OT | 1 |
| Seye, MM | 1 |
| Faye, DS | 1 |
| Sousa-Figueiredo, JC | 1 |
| Yıldırmak, MT | 1 |
| Simşek, F | 1 |
| Gedik, H | 1 |
| Kantürk, A | 1 |
| Polman, K | 3 |
| Stelma, FF | 2 |
| Le Cessie, S | 1 |
| De Vlas, SJ | 2 |
| Falcão Ferreira, ST | 1 |
| Talla, I | 2 |
| Deelder, AM | 2 |
| Gryseels, B | 5 |
| Scott, JT | 2 |
| Diakhaté, M | 1 |
| Vereecken, K | 2 |
| Fall, A | 1 |
| Diop, M | 2 |
| Ly, A | 1 |
| De Clercq, D | 1 |
| Berkvens, D | 1 |
| Kestens, L | 2 |
| Mwanakasale, V | 1 |
| Vounatsou, P | 1 |
| Sukwa, TY | 1 |
| Ziba, M | 1 |
| Ernest, A | 1 |
| Tanner, M | 3 |
| Ernould, JC | 1 |
| Kaman, AK | 1 |
| Sidiki, A | 2 |
| Djibrilla, A | 1 |
| Chippaux, JP | 2 |
| Kim, JS | 1 |
| Jeong, SM | 1 |
| Moon, SY | 1 |
| Park, SH | 1 |
| Saathoff, E | 1 |
| Kvalsvig, JD | 1 |
| Becker, W | 1 |
| Appleton, CC | 1 |
| Guo, XY | 1 |
| He, N | 1 |
| Jiang, QW | 1 |
| Köppen, S | 1 |
| Kellner, U | 1 |
| Huchzermeyer, H | 1 |
| Botros, S | 2 |
| Sayed, H | 1 |
| Amer, N | 1 |
| El-Ghannam, M | 1 |
| Bennett, JL | 1 |
| Day, TA | 1 |
| Bottieau, E | 1 |
| Clerinx, J | 1 |
| de Vega, MR | 1 |
| Van den Enden, E | 1 |
| Colebunders, R | 1 |
| Van Esbroeck, M | 1 |
| Vervoort, T | 1 |
| Van Gompel, A | 1 |
| Van den Ende, J | 1 |
| Booth, M | 1 |
| Shaw, MA | 1 |
| Carpenter, D | 1 |
| Joseph, S | 1 |
| Kariuki, HC | 2 |
| Mwatha, JK | 1 |
| Jones, FM | 1 |
| Ouma, JH | 5 |
| Dunne, DW | 1 |
| Southgate, V | 1 |
| Leenstra, T | 2 |
| Coutinho, HM | 2 |
| Acosta, LP | 2 |
| Langdon, GC | 2 |
| Su, L | 2 |
| Olveda, RM | 2 |
| McGarvey, ST | 2 |
| Kurtis, JD | 2 |
| Friedman, JF | 2 |
| Clyti, E | 1 |
| Khéosang, P | 1 |
| Huerre, M | 1 |
| Sayasone, S | 1 |
| Martinez-Aussel, B | 1 |
| Strobel, M | 1 |
| Jarilla, B | 1 |
| Jiz, MA | 1 |
| Wang, T | 1 |
| Zhang, S | 1 |
| Wu, W | 1 |
| Zhang, G | 1 |
| Lu, D | 1 |
| Ornbjerg, N | 1 |
| Naus, CW | 1 |
| Barnett, K | 1 |
| Emder, P | 1 |
| Day, AS | 1 |
| Selby, WS | 1 |
| Cruz-Gonzalez, I | 1 |
| Martin-Herrero, F | 1 |
| Gonzalez-Santos, JM | 1 |
| Gutierrez-Diez, JA | 1 |
| Sanchez-Ledesma, M | 1 |
| Maree, AO | 1 |
| Massoud, AA | 1 |
| el Kholy, AM | 1 |
| Anwar, WA | 1 |
| Sornmani, S | 3 |
| Vivatanasesth, P | 3 |
| Impand, P | 2 |
| Phatihatakorn, W | 1 |
| Sitabutra, P | 2 |
| Schelp, FP | 2 |
| Patihatakorn, W | 1 |
| Worasan, P | 1 |
| Preuksaraj, S | 1 |
| Walther, M | 1 |
| Bhogal, MS | 1 |
| Etard, JF | 2 |
| Audibert, M | 1 |
| Dabo, A | 2 |
| Wu, Z | 2 |
| Shaoji, Z | 1 |
| Pan, B | 1 |
| Hu, L | 1 |
| Wei, R | 1 |
| Gao, Z | 1 |
| Li, J | 1 |
| Uwe, B | 1 |
| van Dam, GJ | 1 |
| Sow, S | 1 |
| Diaw, M | 1 |
| Sturrock, RF | 2 |
| Doehring-Schwerdtfeger, E | 1 |
| Kardorff, R | 1 |
| Ali, AE | 1 |
| Shaheen, HI | 1 |
| Chagnon, A | 2 |
| Galzin, M | 1 |
| de Jaureguiberry, JP | 1 |
| Boyer, B | 1 |
| Paris, JF | 2 |
| Marlier, S | 1 |
| Carli, P | 2 |
| Bu, K | 1 |
| Yuan, L | 1 |
| Yang, G | 1 |
| Zhu, J | 1 |
| Liu, Q | 1 |
| Kitange, HM | 1 |
| Swai, AB | 1 |
| McLarty, DG | 1 |
| Alberti, KG | 1 |
| Hinz, E | 1 |
| Saowakontha, S | 1 |
| Pipitgool, V | 1 |
| Mason, PR | 1 |
| Patterson, BA | 1 |
| Gupta, SK | 1 |
| Schantz, PM | 1 |
| Donaldson, JS | 1 |
| Shulman, ST | 1 |
| Rowley, AH | 1 |
| Farghaly, AM | 1 |
| Taha, SA | 1 |
| el-Shafei, MA | 1 |
| Nagaty, IM | 1 |
| el Hayawan, IA | 1 |
| Nasr, ME | 1 |
| el Hamshery, AH | 1 |
| Mahmoud, S | 1 |
| Hassan, S | 1 |
| Ibrahim, A | 1 |
| Zidek, Z | 1 |
| Masek, K | 1 |
| Alla, P | 1 |
| Satti, MZ | 1 |
| Sulaiman, SM | 1 |
| Homeida, MM | 1 |
| Younis, SA | 1 |
| Ghalib, HW | 1 |
| Landa García, JI | 1 |
| Alonso, E | 1 |
| Gonzalez-Uriarte, J | 1 |
| Rodriguez Romano, D | 1 |
| Hipgrave, DB | 1 |
| Lam, KS | 1 |
| Faraj, A | 1 |
| Mulholland, RC | 1 |
| Finch, RG | 1 |
| Grogan, JL | 1 |
| Kremsner, PG | 1 |
| Yazdanbakhsh, M | 1 |
| Boyer, AE | 1 |
| Strand, M | 1 |
| Nahlen, BL | 1 |
| Wagatsuma, Y | 1 |
| Aryeetey, ME | 1 |
| Sack, DA | 1 |
| Morrow, RH | 1 |
| Hatz, C | 1 |
| Kojima, S | 1 |
| Mutapi, F | 1 |
| Ndhlovu, PD | 2 |
| Hagan, P | 4 |
| Woolhouse, ME | 1 |
| Wiegand, F | 1 |
| Koeppen, S | 1 |
| Häussermann, P | 1 |
| Delcker, A | 1 |
| Kahama, AI | 1 |
| Kombe, Y | 1 |
| Kihara, RW | 1 |
| Ndzovu, M | 1 |
| Mungai, P | 1 |
| Li, YS | 1 |
| Sleigh, AC | 2 |
| Li, Y | 2 |
| Waine, GJ | 1 |
| Williams, GJ | 1 |
| Ofoezie, IE | 1 |
| Farah, IO | 1 |
| Johansson, M | 1 |
| Lövgren-Bengtson, K | 1 |
| Hau, J | 1 |
| Botros, SS | 1 |
| Makary, EA | 1 |
| Ahmed, KM | 1 |
| Ibrahim, AM | 1 |
| Nashed, NN | 1 |
| El-Nahal, HM | 1 |
| Doughty, BL | 1 |
| Hassanein, HI | 1 |
| Campagne, G | 1 |
| Barkiré, H | 1 |
| Vera, C | 1 |
| Doucoure, B | 1 |
| Koita, O | 1 |
| Diallo, M | 1 |
| Kouriba, B | 1 |
| Klinkert, MQ | 1 |
| Doumbia, S | 1 |
| Doumbo, O | 1 |
| Mduluza, T | 1 |
| Madziwa, TM | 1 |
| Midzi, N | 1 |
| Zinyama, R | 1 |
| Turner, CM | 1 |
| Chandiwana, SK | 1 |
| Nyazema, N | 1 |
| Beck, L | 1 |
| Favre, TC | 1 |
| Pieri, OS | 1 |
| Zani, LC | 1 |
| Domas, GG | 1 |
| Barbosa, CS | 1 |
| N'Goran, EK | 1 |
| N'Guessan, AN | 1 |
| Müller, I | 1 |
| Zamblé, K | 1 |
| Lohourignon, KL | 1 |
| Traoré, M | 1 |
| Sosthène, BA | 1 |
| Lengeler, C | 1 |
| Guo, JG | 1 |
| Lin, DD | 1 |
| Williams, GM | 1 |
| Chen, HG | 1 |
| Davis, GM | 1 |
| Feng, Z | 1 |
| Ayles, HM | 1 |
| Corbett, EL | 1 |
| Taylor, I | 1 |
| Cowie, AG | 1 |
| Bligh, J | 1 |
| Walmsley, K | 1 |
| Bryceson, AD | 1 |
| Lischer, GH | 1 |
| Sweat, SD | 1 |
| Polderman, AM | 1 |
| Engels, D | 1 |
| Bina, JC | 1 |
| King, CH | 1 |
| Muchiri, EM | 1 |
| Klinker, H | 1 |
| Tintelnot, K | 1 |
| Joeres, R | 1 |
| Müller, J | 1 |
| Gross, U | 1 |
| Schmidt-Rotte, H | 1 |
| Landwehr, P | 1 |
| Richter, E | 1 |
| López-Brea, M | 1 |
| Sanz, J | 1 |
| Fandiño, J | 1 |
| Botana, C | 1 |
| Fandiño, C | 1 |
| Rodriguez, D | 1 |
| Gomez-Bueno, J | 1 |
| Borel, E | 1 |
| Segala, C | 1 |
| Zwingenberger, K | 1 |
| Harms, G | 1 |
| Poggensee, U | 1 |
| Steiner, A | 1 |
| Müller, O | 1 |
| Feldmeier, H | 1 |
| Bittencourt, PR | 1 |
| Gracia, CM | 1 |
| Gorz, AM | 1 |
| Mazer, S | 1 |
| Oliveira, TV | 1 |
| Crimmins, D | 1 |
| Collignon, PJ | 1 |
| Dwyer, D | 1 |
| Danta, G | 1 |
| Werler, C | 1 |
| Pungpak, S | 1 |
| Suntharasamai, P | 1 |
| Bensted-Smith, R | 1 |
| Butterworth, AE | 1 |
| Dalton, PR | 1 |
| Koech, D | 1 |
| Mugambi, M | 1 |
| arap Siongok, TK | 1 |
| Wilkins, HA | 2 |
| Blumenthal, UJ | 2 |
| Hayes, RJ | 2 |
| Tulloch, S | 1 |
| el Tayeb, M | 2 |
| Daffalla, AA | 2 |
| Kardaman, MW | 2 |
| See, R | 1 |
| Upatham, ES | 1 |
| Viyanant, V | 1 |
| Brockelman, WY | 1 |
| Kurathong, S | 1 |
| Lee, P | 1 |
| Kraengraeng, R | 1 |
| Mitchell, WG | 1 |
| Crawford, TO | 1 |
| Gabriele, F | 1 |
| Wakelin, D | 1 |
| Palmas, C | 1 |
| Suzuki, Y | 1 |
| Itoh, H | 1 |
| Yonemaru, M | 1 |
| Yamasawa, F | 1 |
| Kobayashi, H | 1 |
| Kanazawa, M | 1 |
| Kawashiro, T | 1 |
| Yokoyama, T | 1 |
| Takeuchi, T | 1 |
| Araki, K | 1 |
| el Igail, AB | 1 |
| Dixon, HG | 1 |
| Greenwood, BM | 1 |
| Tameim, O | 1 |
| Abdu, KM | 1 |
| el Gaddal, AA | 1 |
| Jobin, WR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicity[NCT02769013] | 380 participants (Actual) | Observational | 2016-04-30 | Completed | |||
| The Effect of One Versus Two Praziquantel Treatments on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria in Uganda[NCT00215267] | 540 participants (Anticipated) | Interventional | 2005-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for praziquantel and Recrudescence
| Article | Year |
|---|---|
Recurrent eosinophilic pleuritis caused by sparganum infection: A case report and review of the literature.
Topics: Anthelmintics; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Female; Hum | 2020 |
Implementation of human schistosomiasis control: Challenges and prospects.
Topics: Albendazole; Animals; Anthelmintics; Fresh Water; Global Health; Health Education; Humans; National | 2006 |
[Neurocysticercosis. Current review of the literature based on a long-term study of 2 clinically distinct German cases].
Topics: Brain; Brain Diseases; Combined Modality Therapy; Cysticercosis; Follow-Up Studies; Humans; Hydrocep | 1999 |
[Specific treatment as a weapon for controlling schistosomiasis].
Topics: Adolescent; Brazil; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; He | 1992 |
Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment.
Topics: Acute Disease; Adolescent; Adult; Animals; Black People; Brain Diseases; Calcinosis; Carbamazepine; | 1988 |
9 trials available for praziquantel and Recrudescence
| Article | Year |
|---|---|
Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Child; Drug Administration Schedule; Feces; Female; | 2013 |
Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.
Topics: Age Factors; Animals; Anthelmintics; Child, Preschool; Female; Humans; Infant; Male; Neglected Disea | 2015 |
A pilot project for controlling O. viverrini infection in Nong Wai, Northeast Thailand, by applying praziquantel and other measures.
Topics: Food Contamination; Humans; Isoquinolines; Opisthorchiasis; Opisthorchis; Pilot Projects; Praziquant | 1984 |
Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antibodies, Helminth; Antibody Formation; Child; Chil | 1994 |
Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection.
Topics: Adolescent; Adult; Animals; Antibody Formation; Antigens, Protozoan; Antiplatyhelmintic Agents; Chil | 1998 |
Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Hematuria; Humans; Hydronephrosis; Incidenc | 1992 |
Re-infection in human schistosomiasis mansoni: a prospective field study 18 months after praziquantel therapy.
Topics: Adolescent; Adult; Antigens, CD; Biopterins; Child; Child, Preschool; Democratic Republic of the Con | 1990 |
Praziquantel and oltipraz: the treatment of schoolchildren infected with Schistosoma mansoni and/or Schistosoma haematobium in Gezira, Sudan.
Topics: Child; Female; Humans; Male; Parasite Egg Count; Praziquantel; Pyrazines; Random Allocation; Recurre | 1988 |
Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan.
Topics: Abdomen; Child; Clinical Trials as Topic; Diarrhea; Dose-Response Relationship, Drug; Humans; Isoqui | 1985 |
92 other studies available for praziquantel and Recrudescence
| Article | Year |
|---|---|
Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon.
Topics: Adolescent; Anthelmintics; Child; Child, Preschool; Female; Gabon; Humans; Incidence; Longitudinal S | 2019 |
Medical treatment for an isolated renal multilocular hydatid cyst in an elderly: a case report.
Topics: Aged; Albendazole; Animals; Anticestodal Agents; Drug Therapy, Combination; Echinococcosis; Echinoco | 2020 |
Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
Topics: Adult; Animals; Anthelmintics; Bile Ducts, Intrahepatic; Case-Control Studies; Cholangiocarcinoma; D | 2021 |
Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: Repeated cross-sectional studies.
Topics: Adolescent; Adult; Animals; Child; Cross-Sectional Studies; Female; Humans; Male; Mass Drug Administ | 2021 |
Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
Topics: Adolescent; Animals; Anthelmintics; Child; Cohort Studies; Female; Humans; Incidence; Male; Parasite | 2017 |
Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Bile Duct Neoplasms; Cholangiocarcinoma; Cro | 2019 |
Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis?
Topics: Adolescent; Adult; Aged; Animals; Anthelmintics; Child; Child, Preschool; China; Disease Susceptibil | 2013 |
Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Topics: Adolescent; Animals; Anthelmintics; Biomphalaria; Bulinus; Cameroon; Child; Coinfection; Female; Fol | 2013 |
Reinfection studies of canine echinococcosis and role of dogs in transmission of Echinococcus multilocularis in Tibetan communities, Sichuan, China.
Topics: Animals; Anthelmintics; Antigens, Helminth; Disease Vectors; Dog Diseases; Dogs; Echinococcosis; Ech | 2013 |
Reinfection of dogs with fish-borne zoonotic trematodes in northern Vietnam following a single treatment with praziquantel.
Topics: Animals; Antiparasitic Agents; Dog Diseases; Dogs; Feces; Female; Foodborne Diseases; Male; Praziqua | 2014 |
Safety of the combined use of praziquantel and albendazole in the treatment of human hydatid disease.
Topics: Adult; Aged; Albendazole; Drug Combinations; Echinococcosis; Female; Humans; Magnetic Resonance Imag | 2014 |
High reinfection rate after preventive chemotherapy for fishborne zoonotic trematodes in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Chemoprevention; Child; Feces; Female; Fishes; Foodborne Diseases; | 2014 |
Tandem repeat recombinant proteins as potential antigens for the sero-diagnosis of Schistosoma mansoni infection.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Biomarkers; Disease Models, Animal | 2015 |
Seasonal pattern of Echinococcus re-infection in owned dogs in Tibetan communities of Sichuan, China and its implications for control.
Topics: Animals; Anticestodal Agents; China; Dog Diseases; Dogs; Echinococcosis; Echinococcus; Enzyme-Linked | 2016 |
Mass drug administration and the global control of schistosomiasis: successes, limitations and clinical outcomes.
Topics: Anthelmintics; Disease Eradication; Global Health; Health Promotion; Humans; Praziquantel; Prevalenc | 2016 |
Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.
Topics: Animals; Anthelmintics; B-Lymphocyte Subsets; Eosinophilia; Humans; Male; Occupational Exposure; Pra | 2009 |
Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
Topics: Animals; Anthelmintics; Antibodies, Helminth; B-Lymphocytes; Child; Female; Humans; Immunoglobulin E | 2010 |
Recurrent perirectal abscess.
Topics: Abscess; Animals; Anthelmintics; Anus Diseases; Chronic Disease; Drainage; Endemic Diseases; Humans; | 2010 |
[Temperature recrudescence caused by praziquantel treatment after falling to normal automatically in acute schistosomiasis patients: a report of 19 cases].
Topics: Adolescent; Adult; Body Temperature; Female; Fever; Humans; Male; Praziquantel; Recurrence; Schistos | 2011 |
Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Topics: Adolescent; Animals; Anthelmintics; Child; Cohort Studies; Drug-Related Side Effects and Adverse Rea | 2013 |
Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Topics: Adolescent; Animals; Anthelmintics; Child; Child, Preschool; Coinfection; Feces; Female; Humans; Mal | 2013 |
[A case of persistent urinary schistosomiasis transmitted through Lake Malawi].
Topics: Adult; Anthelmintics; Diagnosis, Differential; Humans; Lakes; Lymphoma, Non-Hodgkin; Malawi; Male; P | 2012 |
Evaluation of the patterns of Schistosoma mansoni infection and re-infection in Senegal, from faecal egg counts and serum concentrations of circulating anodic antigen.
Topics: Adolescent; Adult; Age Factors; Animals; Anthelmintics; Antigens, Helminth; Child; Child, Preschool; | 2002 |
Human water contacts patterns in Schistosoma mansoni epidemic foci in northern Senegal change according to age, sex and place of residence, but are not related to intensity of infection.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Anthelmintics; Child; Disease Outbreaks; Environmenta | 2003 |
Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
Topics: Adolescent; Adult; Animals; Anthelmintics; Child; Cohort Studies; Drug Administration Schedule; Fema | 2003 |
[Heterogeneity of Schistosoma haematobium transmission in irrigated fields].
Topics: Adolescent; Adult; Agriculture; Animals; Bulinus; Child; Child, Preschool; Desiccation; Disease Vect | 2004 |
Third cranial nerve palsy from midbrain neurocysticercosis: repeated exacerbation on tapering corticosteroids.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Blepharoptosis; Cerebrospinal Fluid; Cysticerc | 2004 |
Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
Topics: Adolescent; Age Distribution; Anthelmintics; Child; Cohort Studies; Female; Humans; Male; Parasite E | 2004 |
[Risk factors associated with reinfection of Schistosoma japonicum].
Topics: Adult; Animals; China; Cohort Studies; Female; Humans; Incidence; Logistic Models; Male; Parasite Eg | 2004 |
[Surprising findings in the colon 15 years after a holiday in Africa].
Topics: Abdominal Pain; Aged; Animals; Anthelmintics; Antibodies, Helminth; Colon; Colonoscopy; Female; Germ | 2005 |
Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.
Topics: Adult; Animals; Anthelmintics; Drug Resistance; Egypt; Female; Humans; Liver Diseases, Parasitic; Ma | 2005 |
Imported Katayama fever: clinical and biological features at presentation and during treatment.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Africa South of the Sahara; Anthelmintics; Anti-Inflamma | 2006 |
Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levels.
Topics: Adolescent; Adult; Amino Acid Sequence; Analysis of Variance; Animals; Anthelmintics; Antibodies, He | 2006 |
Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation.
Topics: Adolescent; Adult; Anemia; Anemia, Iron-Deficiency; Animals; Anthelmintics; Child; Cohort Studies; F | 2006 |
Cutaneous paragonimiasis with flare up after treatment: a clinical case from Laos.
Topics: Abscess; Adolescent; Animals; Anthelmintics; Drainage; Female; Humans; Paragonimiasis; Paragonimus; | 2006 |
Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection.
Topics: Adolescent; Adult; Animals; Anthelmintics; C-Reactive Protein; Child; Cytokines; Feces; Female; Huma | 2006 |
Treatment and reinfection of water buffaloes and cattle infected with Schistosoma japonicum in Yangtze River Valley, Anhui province, China.
Topics: Administration, Oral; Age Factors; Animals; Anthelmintics; Buffaloes; Cattle; Cattle Diseases; Chi-S | 2006 |
Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anthelmintics; Antibodies, Helminth; C | 2007 |
Tapeworm infestation: a cause of iron deficiency anemia shown by capsule endoscopy.
Topics: Adolescent; Anemia, Iron-Deficiency; Animals; Australia; Capsule Endoscopy; Emigrants and Immigrants | 2007 |
Images in cardiovascular medicine. Anaphylaxis and recurrent hydatid disease.
Topics: Albendazole; Anaphylaxis; Combined Modality Therapy; Echinococcosis; Heart Diseases; Humans; Middle | 2007 |
Assessment of efficacy of praziquantel against Schistosoma mansoni infection.
Topics: Child; Humans; Isoquinolines; Praziquantel; Recurrence; Schistosoma mansoni; Schistosomiasis | 1984 |
Infection and re-infection rates of opisthorchiasis in the water resource development area of Nam Pong project, Khon Kaen Province, northeast Thailand.
Topics: Diet; Health Education; Humans; Opisthorchiasis; Praziquantel; Recurrence; Sanitation; Thailand; Tim | 1984 |
Experimental chemotherapy of Taenia saginata cysticercosis - a field trial.
Topics: Animals; Cattle; Cattle Diseases; Drug Evaluation; Isoquinolines; Praziquantel; Random Allocation; R | 1983 |
Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali.
Topics: Adolescent; Adult; Age Factors; Animals; Bulinus; Child; Cohort Studies; Disease Vectors; Female; Fo | 1995 |
Reinfection with Schistosoma japonicum after treatment with praziquantel in Poyang lake region, China.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; China; Cohort Studies; Female; Follow-Up St | 1994 |
Human resistance to reinfection with schistosomes. II. Specific IgA titres before & 3 months after praziquantel treatment.
Topics: Adolescent; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Female; Humans; Immunoglobulin A; Immun | 1994 |
[Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
Topics: Adult; Albendazole; Brain Diseases; Cysticercosis; Drug Administration Schedule; Drug Therapy, Combi | 1994 |
Factors contributing to reinfection with schistosomiasis japonica after treatment in the lake region of China.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; China; Female; Fresh Water; Humans; Male; M | 1993 |
Schistosomiasis prevalence after administration of praziquantel to school children in Melela village, Morogoro region, Tanzania.
Topics: Adolescent; Child; Feces; Female; Follow-Up Studies; Hematuria; Humans; Incidence; Male; Morbidity; | 1993 |
Opisthorchiasis control in northeast Thailand: proposal for a new approach.
Topics: Animals; Cat Diseases; Cats; Disease Vectors; Dog Diseases; Dogs; Drug Administration Schedule; Fish | 1994 |
Epidemiology of Hymenolepis nana infections in primary school children in urban and rural communities in Zimbabwe.
Topics: Age Factors; Child; Feces; Female; Follow-Up Studies; Humans; Hygiene; Hymenolepiasis; Intestinal Di | 1994 |
Recurrent hydatid disease after therapy with albendazole.
Topics: Administration, Oral; Adult; Albendazole; Echinococcosis, Hepatic; Follow-Up Studies; Humans; Male; | 1993 |
Experimental schistomiasis: the effect of chemotherapy on concomitant immunity and resistance to reinfection.
Topics: Animals; Immunity, Active; Mice; Praziquantel; Recurrence; Schistosomiasis mansoni; Time Factors | 1993 |
Observations on possible immunity to reinfection among school children after schistosomiasis treatment.
Topics: Animals; Antibodies, Helminth; Antibody Specificity; Antigens, Helminth; Antiplatyhelmintic Agents; | 1996 |
Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibody Formation; Antiplatyhelmintic Agents; Dipeptid | 1996 |
[Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis].
Topics: Adult; Albendazole; Anthelmintics; Brain Diseases; Cysticercosis; Drug Therapy, Combination; Humans; | 1996 |
Clinical, parasitological and immunological features of canal cleaners hyper-exposed to Schistosoma mansoni in the Sudan.
Topics: Adult; Antibodies, Helminth; Antigens, Helminth; Antiplatyhelmintic Agents; Enzyme-Linked Immunosorb | 1996 |
Evaluation of scolicidal agents in an experimental hydatid disease model.
Topics: Animals; Anti-Infective Agents, Local; Antiplatyhelmintic Agents; Disease Models, Animal; Echinococc | 1997 |
A case of refractory schistosomiasis.
Topics: Animals; Antiplatyhelmintic Agents; Drug Resistance; Humans; Praziquantel; Recurrence; Schistosoma; | 1997 |
Medical decompression of vertebral hydatidosis.
Topics: Aged; Albendazole; Anthelmintics; Contraindications; Drug Therapy, Combination; Echinococcosis; Fema | 1997 |
Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Antiplatyhelmintic Agents; CD4 Lymphocyte Count; | 1998 |
Resolution and resurgence of schistosoma haematobium-induced pathology after community-based chemotherapy in ghana, as detected by ultrasound.
Topics: Adolescent; Adult; Analysis of Variance; Animals; Child; Child, Preschool; Community Medicine; Femal | 1999 |
A comparison of re-infection rates with Schistosoma haematobium following chemotherapy in areas with high and low levels of infection.
Topics: Adolescent; Animals; Antibodies, Helminth; Child; Humans; Praziquantel; Prevalence; Recurrence; Schi | 1999 |
Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the coast province of Kenya.
Topics: Adolescent; Animals; Child; Female; Follow-Up Studies; Hematuria; Humans; Kenya; Linear Models; Long | 1999 |
Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antibodies, Helminth; Antigens, Helminth; Child; Chin | 1999 |
Patterns of reinfection following praziquantel treatment of urinary schistosomiasis at a period of low transmission.
Topics: Adolescent; Age Distribution; Animals; Child; Female; Humans; Male; Parasite Egg Count; Praziquantel | 2000 |
Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Cells, Cultured; Concanavalin A; Culture Media; C | 2000 |
Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Drug Therapy, Combination; Glutathione Transferase; Im | 2000 |
[Continued ultrasonic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel].
Topics: Adolescent; Anthelmintics; Child; Data Collection; Female; Hematuria; Humans; Male; Niger; Praziquan | 2001 |
[Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Topics: Adolescent; Age Distribution; Agriculture; Anthelmintics; Child; Female; Humans; Incidence; Male; Ma | 2000 |
The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection.
Topics: Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Child; Endemic Diseases; Follow-Up | 2001 |
Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up.
Topics: Animals; Anthelmintics; Brazil; Crops, Agricultural; Follow-Up Studies; Humans; Oxamniquine; Parasit | 2001 |
Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d'Ivoire.
Topics: Adolescent; Animals; Anthelmintics; Child; Child, Preschool; Cote d'Ivoire; Disease-Free Survival; F | 2001 |
A baseline study on the importance of bovines for human Schistosoma japonicum infection around Poyang Lake, China.
Topics: Adolescent; Adult; Animals; Anthelmintics; Cattle; Cattle Diseases; Child; Child, Preschool; China; | 2001 |
A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Anticestodal Agents; Child; Combined Modality T | 2002 |
16-year-Old boy with gross hematuria.
Topics: Adolescent; Animals; Anthelmintics; Biopsy; Cystoscopy; Hematuria; Humans; Male; Praziquantel; Recur | 2002 |
Experiences with the control of schistosomiasis mansoni in two foci in central Africa.
Topics: Adult; Animals; Biomphalaria; Burundi; Child; Democratic Republic of the Congo; Disease Reservoirs; | 1992 |
[Taenia crassiceps infection in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Back; Cysticercosis; Cysticercus; Diagnosis, Dif | 1992 |
[Chemotherapy in echinococcosis].
Topics: Albendazole; Anthelmintics; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Therapy, Combina | 1991 |
Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy.
Topics: Calcinosis; Cerebral Ventricles; Cerebral Ventriculography; Cerebrospinal Fluid Shunts; Cysticercosi | 1991 |
Schistosoma haematobium infection in Mauritania: two years of follow-up after a targeted chemotherapy--a life-table approach of the risk of reinfection.
Topics: Adolescent; Adult; Age Factors; Animals; Child; Cohort Studies; Female; Follow-Up Studies; Humans; I | 1990 |
High-dose praziquantel for neurocysticercosis: efficacy and tolerability.
Topics: Adolescent; Adult; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Cystice | 1990 |
Neurocysticercosis: an under-recognized cause of neurological problems.
Topics: Adolescent; Adult; Aged; Australia; Cysticercosis; Diagnosis, Differential; Emigration and Immigrati | 1990 |
Efficiency of focal molluscicide treatment against schistosomiasis reinfection in an irrigation scheme and in a small dams area in Mali. Preliminary communication.
Topics: Animals; Disease Vectors; Fresh Water; Humans; Mali; Molluscacides; Praziquantel; Recurrence; Schist | 1989 |
Ultrasonographic study of the biliary system in opisthorchiasis patients after treatment with praziquantel.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Feces; Female; Gallbladder; Humans; Liver; Male | 1989 |
Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment.
Topics: Adolescent; Adult; Age Factors; Child; Female; Humans; Immunity; Immunity, Innate; Male; Middle Aged | 1987 |
Resistance to reinfection after treatment of urinary schistosomiasis.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Female; Humans; Male; Parasite Egg Count; P | 1987 |
Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy.
Topics: Age Factors; Humans; Opisthorchiasis; Praziquantel; Recurrence; Thailand; Time Factors | 1988 |
Specific cross-immunity between Hymenolepis nana and H. diminuta: immunization with heterologous and homologous light infections.
Topics: Animals; Cross Reactions; Female; Hymenolepiasis; Immunization; Immunologic Memory; Mice; Mice, Inbr | 1988 |
[A case of Paragonimus westermani infection with repeated spontaneous pneumothorax and cerebellar infarction--a review of the clinical feature in cases of paragonimiasis reported in Japan for the last 15 years].
Topics: Adult; Cerebral Infarction; Humans; Lung Diseases, Parasitic; Male; Paragonimiasis; Pneumothorax; Pr | 1987 |
Eosinophilia and resistance to Schistosoma haematobium in man.
Topics: Adolescent; Antibody-Dependent Cell Cytotoxicity; Child; Disease Susceptibility; Eosinophilia; Eosin | 1985 |
Protection of Sudanese irrigation workers from schistosome infections by a shift to earlier working hours.
Topics: Adult; Agriculture; Feces; Humans; Male; Middle Aged; Occupational Diseases; Parasite Egg Count; Per | 1985 |